News Wire ~ 3rd Party Press Release

213 POSTS 0 COMMENTS
AR101

New Treatment to Protect People with Peanut Allergies Ready for FDA Review

"Two thirds of the people in the study were able to tolerate the equivalent of two peanuts per day after 9 to 12 months of treatment."
Allergy Shot

Severe Eczema May Best Be Treated by Allergy Shots

Significant benefits seen in one medically challenging case.
Dentritic Cells

Using Mice, Duke Researchers Identify How Allergic Shock Occurs So Quickly

A newly identified immune cell mines the blood for allergens to directly trigger inflammation.
Epitope Mapping

Mount Sinai and AllerGenis Announce Partnership to Bring Novel, Precision Diagnostics to Food Allergy...

The technology will provide an improved method for detecting, assessing, and monitoring food allergies in patients.
EpiPen and Carrier

FDA Alert: Some EpiPen Auto-Injectors May Not Readily Slide Out of Carrier Tube

In some cases, the patient or caregiver may not be able to quickly remove the epinephrine auto-injector from the carrier tube.
Sesame Seeds

FDA Commissioner's Statement on the Consideration of Labeling for Sesame as Allergen

"The FDA is advancing a new effort for the consideration of labeling for sesame to help protect people who have sesame allergies."
Researcher

ConsortiaTX Awarded Exclusive License for Food Allergy Microbial Therapy

The company is developing therapies for food allergies based on bacteria found in the human gut microbiome.
Viaskin Peanut

DBV Applies for FDA License to Sell Viaskin Peanut Patch Therapy

"This submission represents a significant step forward for those families living with peanut allergy."